Group items tagged

Research on Global Markets has announced the addition of "Celiac Disease Global Clinical Trials Review, H2, 2013"research report to their offering. This report celiac disease global clinical trials review, h2, 2013 provides elemental information and data relating to the clinical trials on celiac disease.

In this report, we have analyzed the market opportunity of Rituximab Biosimilar and its competitive landscape. We believe that despite several clinical setbacks in the Rituxan biosimilars pipeline, they could pose a challenge to Rituximab by 2018.